ResMed reported $201.77M in Cash and Equivalent for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Ansell ANN:AU $ 179.8M 54.4M
Cochlear COH:AU $ 553.1M 56.5M
Fisher & Paykel Healthcare FPH:AU 89.9M 13.3M
Japara Healthcare JHC:AU 43.55M 7.94M
Nanosonics Ltd NAN:AU 240K 3.88M
Opthea Ltd OPT:AU 81.63M 21.02M
Regis Healthcare REG:AU 43.96M 40.07M
ResMed RMD:AU $ 201.77M 7.29M